financetom
Business
financetom
/
Business
/
Oracle's Risk/Reward Leans Negative Ahead of Q2 Report Due to High Cloud Infrastructure Expectations, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oracle's Risk/Reward Leans Negative Ahead of Q2 Report Due to High Cloud Infrastructure Expectations, RBC Says
Dec 5, 2024 9:37 AM

12:12 PM EST, 12/05/2024 (MT Newswires) -- Oracle's (ORCL) "risk/reward tradeoff" is leaning "negative" ahead of its fiscal Q2 report, primarily due to high expectations for Oracle Cloud Infrastructure, RBC Capital Markets said in a report Thursday.

The analysts said they believe "the setup is tricky, and remain on the sidelines ahead of results."

"We expect Oracle to report slight upside relative to consensus expectations in line with [fiscal Q1] outperformance," which translates to 10% year-over-year growth, RBC said, adding that it expects adjusted EPS of around $1.50, which would exceed expectations, aligning with recent average beats.

Oracle's OCI cloud revenue is expected to grow 24% year-over-year. However, OCI consumption revenue growth is expected to decelerate, potentially leading to a mismatch with expectations.

The company is due to report fiscal Q2 results on Dec. 9 after the market closes.

RBC maintained its sector perform rating on Oracle with a price target of $165.

Price: 187.29, Change: -0.90, Percent Change: -0.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corbus Says FDA Grants Fast-Track Designation to Head and Neck Cancer Drug
Corbus Says FDA Grants Fast-Track Designation to Head and Neck Cancer Drug
Sep 16, 2025
08:28 AM EDT, 09/16/2025 (MT Newswires) -- Corbus Pharmaceuticals ( CRBP ) said Tuesday that its head and neck squamous cell carcinoma drug CRB-701 was granted Fast Track designation by the US Food and Drug Administration. The company said that a phase 1/2 trial is currently evaluating the safety, pharmacokinetics and efficacy of CRB-701 in patients with advanced solid tumors...
CrowdStrike, Salesforce Form Partnership to Boost Security of AI Agents, Applications
CrowdStrike, Salesforce Form Partnership to Boost Security of AI Agents, Applications
Sep 16, 2025
08:29 AM EDT, 09/16/2025 (MT Newswires) -- CrowdStrike ( CRWD ) said Tuesday it formed a partnership with Salesforce ( CRM ) aiming to improve the security of AI agents and applications via integrations between Falcon Shield and Salesforce Security Center. The partnership will also allow customers to access CrowdStrike's ( CRWD ) agentic security analyst Charlotte AI in the...
Form 8.3 - American Axle & Manufacturing Holdings Inc
Form 8.3 - American Axle & Manufacturing Holdings Inc
Sep 16, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Arrowstreet Capital, Limited Partnership (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
CleanCore Acquires Additional 100 Million DOGE, Expanding Digital Asset Treasury to Over 600 Million DOGE
CleanCore Acquires Additional 100 Million DOGE, Expanding Digital Asset Treasury to Over 600 Million DOGE
Sep 16, 2025
OMAHA, Neb., Sept. 16, 2025 (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. ( ZONE ) (“CleanCore” or the “Company”), today announced that it has acquired an additional 100 million Dogecoin (“DOGE”), bringing the total holdings of its Official Dogecoin Treasury (the “Treasury”) to more than 600 million DOGE. The Treasury, backed by the Dogecoin Foundation and its corporate arm, House of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved